API Ceftazidime CAS 72558-82-8 Pharmaceutical Ceftazidime Powder Raw Material Ceftazidime

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung-Ceftazidime
• Product Name: Ceftazidime
• Name: Ceftazidime Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC, UV
• Shelf Life: 2 Years
• CAS No.: 72558-82-8
• Mf: C22h22n6o7s2
• MW: 546.58
• Storage Conditions: 2-8 C
• HS: 29419000
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 8000kg/Month

Product Description

API Ceftazidime CAS 72558-82-8 Pharmaceutical Ceftazidime powder Raw material Ceftazidime

Product Description

Product Details

Product Name	Ceftazidime
CAS No.	72558-82-8
Molecular Formula	C22H22N6O7S2
Molecular Weight	546.58
Specification	99%
Appearance	White Powder

Ceftazidime (Ceftazidime) is the third generation cephalosporin. The pneumococcus, Streptococcus and Staphylococcus aureus and gram positive bacteria was weaker than cefazolin; resistant to Staphylococcus aureus and Enterococcus methicillin ineffective against gram negative bacteria; just as powerful, such as good on Escherichia coli, Klebsiella pneumoniae, proteus, Sha Lei bacteria, bacillus, influenza Pseudomonas aeruginosa, Neisseria gonorrhoeae, meningococcal has antibacterial activity; gram positive anaerobic aerobic bark on Motoki Shinami, but the resistance of Bacteroides fragilis.
It is also used for the lower respiratory tract, skin and soft tissue, bone and joint, thoracic cavity, abdominal cavity, urogenital system and central infection caused by sensitive strains of Gram-negative bacteria. It is also used for septicemia.

Application&Function

1.For pneumonia and lower respiratory tract infection caused by Gram-negative bacilli, intraperitoneal and biliary tract infections, complex urinary tract infections and severe skin and soft tissue infections, etc. It is especially suitable for immunodeficiency caused by multi-drug resistant Gram bacilli, nosocomial infection and infection of central nervous system caused by Gram-negative bacilli or Pseudomonas aeruginosa.
2. It is clinically used for general severe infections caused by sensitive bacteria (such as sepsis, meningitis, bacteremia), respiratory tract infections (such as pneumonia, bronchitis), ear, nose and throat infections, skin and soft tissue infections, urinary tract infections, gastrointestinal, biliary and abdominal infections, bone and joint infections, etc.

Specification